Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of the Second Generation of the Controlled Attenuation Parameter (CAP) Using the MRI-PDFF as Reference

NCT03704792 is registered in ClinicalTrials.gov with Echosens as lead sponsor.

NCT NCT03704792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03704792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of the Second Generation of the Controlled Attenuation Parameter (CAP) Using the MRI-PDFF as Reference
Lead sponsor
Echosens
Phase
Not applicable
Overall status
Completed
Start date
September 24, 2019
Completion date
November 30, 2021
Enrollment
207 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic liver disease